PRP is an autologous biologic treatment prepared from a patient's own blood and injected into a selected musculoskeletal target.
A small amount of blood is processed to concentrate platelets in plasma. The resulting preparation is injected into a selected joint, tendon, ligament, or other soft-tissue target. Evidence and expected benefit vary by diagnosis, tissue, preparation method, and patient factors.
Candidacy depends on the diagnosis, prior treatment, examination, imaging when appropriate, medical history, and the expected risk-benefit profile.
A specific musculoskeletal diagnosis with a reasonable biologic-treatment rationale
Persistent symptoms despite appropriate first-line care
Realistic expectations regarding condition-dependent benefit
No contraindication to autologous blood collection or injection
Clinical diagnosis and imaging review when appropriate
Blood draw and centrifugation to prepare PRP
Image-guided injection into the selected target when appropriate
Diagnosis-specific activity and rehabilitation plan
Potential risks include temporary pain flare, bleeding, bruising, infection, tissue or nerve injury, vasovagal symptoms, and lack of meaningful benefit. PRP is not proven to regenerate every injured or degenerative tissue, and outcomes vary.
Results vary, and no procedure can guarantee pain relief or functional improvement.